Researchers around the world are successfully accelerating breakthroughs to treat our most devastating diseases.
Brooks Life Sciences is proud to partner with these scientists and support the search for cures with the industry’s most complete portfolio of sample management solutions.
Our products, services, and technology are empowering advancements and creating hope for the delivery of healthier and brighter tomorrows for people everywhere.
The world’s top researchers trust Brooks to help them nurture chemical compounds and biological samples used to discover, develop, and deliver new medicines and therapies.
Count on our global team of experts to customize solutions that safely handle any stage in the sample lifespan — planning, collection, transport, processing, storage, analytics, retrieval, and disposal.
Whether your life’s work is dedicated to discovering new products, finding tomorrow’s cures, or supporting people who do either form of research, Brooks is ready to serve your organization.
Brooks Life Sciences acquires GENEWIZ, the leading provider of gene sequencing and synthesis services worldwide. GENEWIZ brings more than 4,000 institutional customers worldwide supported by their global network of laboratories.
Brooks Life Sciences acquires BioSpeciMan, a privately held biobank for biological sample materials for contract research organizations and pharmaceutical companies developing and manufacturing off-patient therapeutics. BioSpeciMan adds significant customer relationships in the generic pharmaceuticals market and geographic biobank expansion into Canada.
Brooks Life Sciences acquires 4titude, Ltd, a privately held manufacturer of scientific consumables for biological sample materials used in a variety of genomic and DNA analytical applications. 4titude is widely recognized for its innovative range of Polymerase Chain Reaction (PCR) plates, seals, and related benchtop instrumentation.
Brooks Life Sciences acquires certain assets from RURO, Inc. These assets include the FreezerPro® web-based software and an exclusive license agreement to sell and distribute BioBankPro® software. FreezerPro and BioBankPro expand Brooks' software offerings into a full range of informatic solutions that address any size laboratory, biobank, or enterprise that manages biological samples.
Brooks Life Sciences acquires Pacific Bio-Material Management, Inc, a premier provider of biobank storage and cold-chain logistics for biological sample materials. The purchase improves our ability to provide to US customer nationwide transport, cold-chain transport and relocation services from coast-to-coast – as well as storage of precious research samples.
Brooks Life Sciences buys Cool Lab, LLC, a subsidiary of BioCision, LLC. The purchase culminates a two-year collaboration between the two companies that has developed new products designed to bring customers advanced temperature control solutions and better sample integrity, quality, and utility across the cold chain of custody.
Eyeing improved efficiencies and more extensive sample management solutions for its broad customer base, Brooks Life Sciences buys BioStorage Technologies, Inc, an Indianapolis-based company known as an industry leader in comprehensive sample lifecycle management of biological samples for multiple markets. The acquisition of BioStorage Technologies gives the pharmaceutical, biotech, clinical, healthcare, academic, and government sectors access to comprehensive resources for outsourced services throughout the life of biological samples and allows Brooks to offer more robust systems for sample data management.
Expanding its ability to offer advanced sample storage products to researchers, Brooks Life Sciences acquires FluidX, a British company and leader in 2D tube technology, consumable products, and instrumentation designed to protect biological samples. The acquisition positions Brooks to expand its product line with state-of-the-art sample storage consumables, 2D readers, tri-code tubes, as well as and capping and decapping instruments.
Brooks Life Sciences acquires 22 percent equity interest in BioCision LLC and agrees to make subsequent investments of $5 million. These investments strengthen the Brooks line of cryopreservation products designed to improve and standardize tools and methods for biomaterial sample handling.
The acquisition of Matrical Inc. enhances the Brooks Life Sciences line of biological sample preparation, management, and storage solutions. This $10-million investment expands capabilities for customers in the agriculture, biotech, life science, and pharmaceutical markets.
Brooks Life Sciences buys the cellular imaging system unit of Cyntellect, Inc. The acquisition allows Brooks to expand its product line with cellular imaging technology for high-throughput research environments.
A $79 million purchase of Nexus Biosystems Inc. strengthens Brooks’ position as a leading innovator in biobanking and compound sample management. The acquisition brings customers advanced technology and worldwide access to sales and support of Brooks Life Sciences sample management solutions.
Brooks Automation identifies life sciences as an underserved market where our core competencies in automation and cryogenic solutions can serve researchers and grow our business. In 2011, Brooks acquires RTS Life Sciences – an acquisition that started us a path toward becoming a worldwide leader in automated sample storage systems.